Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Japan study shows women more likely to get skin rash from Moderna shot
The study of 5,893 participants between May and November last year showed that 22.4 per cent of women developed delayed skin…
FDA withdraws approval for TG Therapeutics cancer treatment
The withdrawal has been due to concerns of higher risk of death in patients receiving the drug
Canada authorises Pfizer COVID-19 booster for 16 and 17-year-olds
The decision was based on data from two studies of the booster shot among individuals aged 16 years and older
Sage-Biogen drug improves symptoms in postpartum depression study
The drug, Zuranolone, also reduced depression severity as early as the third day of treatment compared with placebo in the study…
Mankind Pharma offers seed funding to EzeRx
The fund raised will be used for scaling up its operations and marketing along with boosting its sales in various markets across…
Enabling CROs, pharma, healthcare and lifesciences industries with disruptive e-signature and smart…
Srini Dokka, Global Sales Head, MSB Docs, explains the role of digital signatures that is giving an edge in this patient care,…
Green packaging: A huge responsibility
As the world can't afford another Great Pacific Dump, the pharma industry needs to be responsible enough with its packaging…
Vietnam develops ‘world’s first’ African swine fever vaccine for commercial use
The vaccine has been in development since November 2019 in partnership with the US experts, with five clinical trials held
Amgen announces positive phase-II data for investigational Olpasiran in adults with elevated…
The study showed significant and sustained reduction in lipoprotein(a) during treatment period
US FDA grants efanesoctocog alfa breakthrough therapy designation for hemophilia A
The designation is based on Xtend-1 phase-III study data demonstrating a clinically meaningful prevention of bleeds and…